Answer:
Matter cycles through an ecosystem through processes called biogeochemical cycles.
Explanation:
Photosynthesis
Plants build carbohydrates by taking in carbon dioxide from the atmosphere.
Carbon moves through the food chain
As organisms eat other organisms, carbon moves up the food chain. Molecules in the food that contain carbon transform into the organic molecules that make up the living body.
Carbon moves back to the environment
Organisms use food molecules, containing carbon, as a form of energy. The process of cellular respiration breaks down food molecules into carbon dioxide.
Contribution of industry
Humans contribute to moving carbon dioxide back into the atmosphere through the combustion of fossil fuels.
Use of fossil fuels
Today's fossil fuels were formed hundreds of millions of years ago by plants deposited in the Earth. The decomposition of the plants slowed down in such a way that their organic molecules are used for natural gas, coal and oil.
Diffusion into the air
From the oceans, carbon dioxide diffuses into the air. This creates a large amount of carbon, which is then taken in by plants to start the cycle over again.
Answer:
ANOTHER ANTIBODY MOLECULE OR A
Explanation:
I just know
Today, the Earth's axis is tilted 23.5 degrees from the plane of its orbit around the sun.
These are biosphere and hydrosphere.
Answer:
Explanation:
iPSC (induced Pluripotent Stem Cell) induces differentiated cardiomyocytes (cardiomyocytes, CM), which are human, good uniformity, high purity, and have unique properties of cardiomyocytes such as contractile function, action potential and ion channels.
<em>Genetic mutation is an important factor that contributes to the pathogenesis and development of Alzheimer’s disease (AD). The genetic factors studied include the dominant mutations of genes encoding amyloid-β precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2). Additionally, more and more genes have been found to be potentially associated with AD, such as apolipoprotein E (APOE), glycogen synthase kinase 3 beta (GSK3B), dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), and Tau. Although many studies on the treatment of AD have not been successful, gene therapy is still considered as a potential way against AD, and some gene-therapy-based therapeutics have entered the clinical trial stage. Existing strategies for gene therapy against AD include gene inactivation, genetic modification, and immunoregulation, etc. </em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/gene-therapy/</em>